235 related articles for article (PubMed ID: 7805372)
1. Improved utilization of spacing methods--intrauterine devices (IUDs) and low-dose combined oral contraceptives (OCs)--through re-orientation training for improving quality of services. Indian Council of Medical Research Task Force on IUD and Hormonal Contraceptives.
Contraception; 1994 Sep; 50(3):215-28. PubMed ID: 7805372
[TBL] [Abstract][Full Text] [Related]
2. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
Reinprayoon D; Gilmore C; Farr G; Amatya R
Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
[TBL] [Abstract][Full Text] [Related]
4. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
Arowojolu AO; Otolorin EO; Ladipo OA
Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
6. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
7. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
[TBL] [Abstract][Full Text] [Related]
8. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
9. [The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD
Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
[TBL] [Abstract][Full Text] [Related]
10. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
11. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
Andrade AT; de Souza JP; Rowe PJ; Shaw ST
Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
[TBL] [Abstract][Full Text] [Related]
12. Acceptability study of the two versus three monthly injectable contraceptives.
Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the TCu 380A versus TCu 200 IUDs in Nepal.
Shrestha M; Hurst C; Farr G; Amatya R; Tucker B; Mcmaham J
Asia Pac Popul J; 1995 Jun; 10(2):15-26. PubMed ID: 12319865
[TBL] [Abstract][Full Text] [Related]
14. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
Lavin P; Waszak C; Bravo C
Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
[TBL] [Abstract][Full Text] [Related]
15. Use-effectiveness of oral and intrauterine contraception.
Tietze C; Lewitt S
Fertil Steril; 1971 Aug; 22(8):508-13. PubMed ID: 5110233
[TBL] [Abstract][Full Text] [Related]
16. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.
Oddens BJ
Contraception; 1999 May; 59(5):277-86. PubMed ID: 10494480
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B). A 36-month study. Indian Council of Medical Research Task Force on IUD.
Baveja R; Bichille LK; Coyaji KJ; Engineer AD; Gogoi MP; Hazra MN; Kochhar M; Lahiri BC; Manuel M; Nanda UK
Contraception; 1989 Jan; 39(1):37-52. PubMed ID: 2491981
[TBL] [Abstract][Full Text] [Related]
18. [The acceptability of current contraceptive methods to adolescents].
Sotnikova EI; Dubnitskaia LV; Perminova SG
Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of endometriosis in women attending family planning clinics.
Vessey MP; Villard-Mackintosh L; Painter R
BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
[TBL] [Abstract][Full Text] [Related]
20. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD.
Rivera R; Chen-Mok M; McMullen S
Contraception; 1999 Sep; 60(3):155-60. PubMed ID: 10640159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
